Esketamine, a new treatment for resistant depression: a systematic review of the literature

Esketamine, a new treatment for resistant depression: a systematic review of the literature

Bibliographic Details
Main Authors:	Mercedes Valtueña García, Carina Ludwig, Aida González Suárez, Jaime López Fernández, Covadonga Huergo Lora, Sergio Ocio León, Laura Lago García
Format:	Article
Language:	English
Published:	Instituto Psiquiatría Psicodex SL 2021-07-01
Series:	Psicosomática y Psiquiatría
Subjects:	Esketamine
Online Access:	https://raco.cat/index.php/PsicosomPsiquiatr/article/view/390310

Similar Items

The role of intranasal esketamine in treatment-resistant depression
by: A. Fraga, et al.
Published: (2021-04-01)

The cognitive effects of esketamine: what do we know so far?
by: M. Barbosa, et al.
Published: (2022-06-01)

Clinical stability after compassionate use of intranasal esketamine in treatment-resistant depression
by: D. Hernandez Huerta, et al.
Published: (2022-06-01)

How effective are ketamine or esketamine in treatment-resistant depression?
by: N. Veluri, et al.
Published: (2021-04-01)

Esketamine and Psilocybin—The Comparison of Two Mind-Altering Agents in Depression Treatment: Systematic Review
by: Dominika Psiuk, et al.
Published: (2022-09-01)

Impact of Repeated Doses of Subcutaneous Esketamine on Acute Dissociative Symptoms in Treatment-Resistant Depression
by: Lorena Catarina Del Sant, et al.
Published: (2022-12-01)

Heterogeneous trajectory of depressive symptoms after repeated subcutaneous esketamine injections
by: Matheus Ghossain Barbosa, et al.
Published: (2021-01-01)

Case report: Intranasal esketamine for severe major depressive disorder with psychotic features
by: Maximilian Carter, et al.
Published: (2022-07-01)

Early real-life evaluation of the efficacy of esketamine in resistant depressive disorder
by: S. Faisant, et al.
Published: (2022-06-01)

Clinical efficacy and tolerability of Esketamine: a case series
by: C. Passani, et al.
Published: (2022-06-01)

Current research hotspot and future development trend of esketamine: A bibliometric analysis
by: Li Xian, et al.
Published: (2023-10-01)

A propósito de un caso: depresión con delirio de negación de Cotard
by: Carina Ludwig, et al.
Published: (2021-07-01)

Montgomery‐Åsberg Depression Rating Scale factors in treatment‐resistant depression at onset of treatment: Derivation, replication, and change over time during treatment with esketamine
by: Stephane Borentain, et al.
Published: (2022-12-01)

Intranasal esketamine use in bipolar disorder: A case report
by: Courtney Skriptshak, PharmD, et al.
Published: (2021-07-01)

Esketamine pretreatment during cesarean section reduced the incidence of postpartum depression: a randomized controlled trail
by: Shixia Xu, et al.
Published: (2024-01-01)

Use of intranasal esketamine in a girl with treatment-resistant depression and autism spectrum disorders
by: Miriam Olivola, et al.
Published: (2022-02-01)

Research advances in the clinical application of esketamine
by: Xiao‐Xi Zhang, et al.
Published: (2022-03-01)

Treating with esketamine nasal, will increase blood pressure?
by: V. Rosello-Molina, et al.
Published: (2021-04-01)

Esketamine in patient with treatment resistant depression: Outcome of the temporary authorization for use programme in France
by: E. Gaudre Wattinne, et al.
Published: (2021-04-01)

Repeated, low-dose oral esketamine in patients with treatment-resistant depression: pilot study
by: Sanne Y. Smith-Apeldoorn, et al.
Published: (2022-01-01)

Intranasal Esketamine + CBT: a 6 months follow-up of a resistant depression complicated case
by: V. Martiadis, et al.
Published: (2022-06-01)

Effect of Sleep Disturbance on Efficacy of Esketamine in Treatment-Resistant Depression: Findings from Randomized Controlled Trials
by: Borentain S, et al.
Published: (2021-11-01)

Safety and efficacy of esketamine for postoperative analgesia in pediatric patients with hypospadias
by: Yong Xu, et al.
Published: (2023-04-01)

Effect of postoperative application of esketamine on postoperative depression and postoperative analgesia in patients undergoing pancreatoduodenectomy: a randomized controlled trial protocol
by: Kaili Yu, et al.
Published: (2023-08-01)

Short-term cognitive effects of repeated-dose esketamine in adolescents with major depressive disorder and suicidal ideation: a randomized controlled trial
by: Xiaofeng Lan, et al.
Published: (2023-09-01)

Effect of pretreatment with a small dose of esketamine on sufentanil-induced cough during anesthesia induction: a randomized controlled trial
by: Liangliang Gao, et al.
Published: (2024-03-01)

Ideación suicida reactiva a patología somática
by: Covadonga Huergo Lora, et al.
Published: (2021-07-01)

Repeated oral esketamine in patients with treatment resistant depression and comorbid posttraumatic stress disorder
by: J.K.E. Veraart, et al.
Published: (2023-05-01)

Efficacy and Safety of Esketamine Combined with Antidepressants for Treatment-Resistant Depression: A Meta-Analysis
by: Liu P, et al.
Published: (2022-12-01)

Effect of esketamine on postoperative depressive symptoms in patients undergoing thoracoscopic lung cancer surgery: A randomized controlled trial
by: Shu-lin Gan, et al.
Published: (2023-03-01)

The efficacy and safety of esketamine in the treatment of major depressive disorder with suicidal ideation: study protocol for a randomized controlled trial
by: Haiyan Liu, et al.
Published: (2022-11-01)

Comparison of remifentanil and esketamine in combination with propofol for patient sedation during fiberoptic bronchoscopy
by: Jia Nie, et al.
Published: (2023-07-01)

Esketamine versus placebo on time to remission in major depressive disorder with acute suicidality
by: Dong-Jing Fu, et al.
Published: (2023-08-01)

Repeated intravenous esketamine treatment in patients with ECT-resistant major depressive disorder
by: A. Safai Pour, et al.
Published: (2022-12-01)

A comparison between patients who suffer from major depression and are treated with Esketamine – one group participates in group therapy and the other one does not
by: H. Yaniv, et al.
Published: (2022-06-01)

Case report: Intramuscular ketamine or intranasal esketamine as a treatment in four patients with major depressive disorder and comorbid anorexia nervosa
by: Johanna Louise Keeler, et al.
Published: (2023-05-01)

Case report: Effectiveness of brexpiprazole and esketamine/ketamine combination: A novel therapeutic strategy in five cases of treatment-resistant depression
by: Lai Fong Chan, et al.
Published: (2022-07-01)

Efficacy and safety of esketamine combined with propofol for curative endoscopic resection in colorectum: a prospective, randomized controlled trial
by: Yimei Ma, et al.
Published: (2024-03-01)

The Efficacy and Safety of Remimazolam Besylate Combined with Esketamine for Outpatient Colonoscopy: A Prospective, Randomized, Controlled Clinical Trial
by: Li W, et al.
Published: (2023-09-01)

Long-Term Efficacy of Intranasal Esketamine in Treatment-Resistant Major Depression: A Systematic Review
by: Enrico Capuzzi, et al.
Published: (2021-08-01)